title: Parvovirus B19 infection: association with third-trimester intrauterine fetal death.
abstract: OBJECTIVE
  To identify the presence of parvovirus B19 infection as a possible cause of fetal loss in the third trimester.
  
  
  METHODS
  Prospective study of women experiencing third-trimester intrauterine fetal death (IUFD).
  
  
  METHODS
  All cases of IUFD at Danderyd Hospital from 1992 to 1998.
  
  
  METHODS
  Ninety-three women with IUFD in 33,759 deliveries (0.3%).
  
  
  METHODS
  Detection of B19 DNA by polymerase chain reaction (PCR) in placental and fetal tissue. Placental pathology and B19-specific immunohistochemistry. Maternal serology in consecutive samples.
  
  
  RESULTS
  Among 93 cases of IUFD, seven (7.5%) had detectable B19 DNA in freshly-frozen placental tissue. The detection of B19 DNA in these tissues was confirmed by detection of B19 DNA in six separately stored paraffin-embedded placental tissues. No other explanations for the fetal deaths were found. None of the women had experienced any clinical signs of infection prior to fetal demise. None of the seven fetuses were hydropic. Histopathologic examination of the placentas revealed only minor abnormalities. Serology on maternal samples at birth revealed delayed or absent B19 IgG responses in five of seven cases. Two women were B19 IgG seropositive at the time of delivery but had unusual infection patterns; persistent viraemia for at least five months before birth in one case and likely persistence or re-infection by B19 in the other.
  
  
  CONCLUSIONS
  In our study, 7.5% of IUFDs in the third trimester may have been caused by parvovirus B19 infection, without signs of fetal hydrops. This finding indicates that B19 PCR should be included in the routine investigation of IUFD.
authors.affiliation: Division of Obstetrics and Gynaecology, Karolinska Institutet, Danderyd Hospital, Sweden.
authors.forename: L
authors.initials: L
authors.lastname: Skjöldebrand-Sparre
authors.forename: T
authors.initials: T
authors.lastname: Tolfvenstam
authors.forename: N
authors.initials: N
authors.lastname: Papadogiannakis
authors.forename: B
authors.initials: B
authors.lastname: Wahren
authors.forename: K
authors.initials: K
authors.lastname: Broliden
authors.forename: M
authors.initials: M
authors.lastname: Nyman
mesh_terms: D000328:Adult; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D005313:Fetal Death / Q000821:virology*; D006801:Humans; D010322:Parvoviridae Infections / Q000150:complications*; D016732:Parvovirus B19, Human / Q000235:genetics; D010920:Placenta / Q000473:pathology; D016133:Polymerase Chain Reaction; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000821:virology*; D011263:Pregnancy Trimester, Third; D011446:Prospective Studies; D013548:Sweden
chemical_list: D004279:DNA, Viral